AI Rights for Scientific Literature: What You Need to Know
Learn how biotech startups and established pharmaceutical companies are solving the compliance challenge with the AI Rights add-on for Article Galaxy.
Register Now💻 Live on Zoom
🗓️ Wednesday, December 3rd at 10 am EST
The Challenge Facing Life Sciences Researchers Today
In an era where 76% of life sciences researchers now rely on AI tools to discover and analyze scientific literature, a critical compliance gap has emerged. Most scientific publishers explicitly prohibit the use of their content in AI applications without proper permissions—yet no streamlined mechanism exists for acquiring these necessary rights.
This creates significant risk for biotech and pharmaceutical organizations where researchers routinely analyze journal articles with tools like Microsoft Copilot, ChatGPT, and Claude to accelerate discovery workflows, identify drug targets, validate biomarkers, and extract actionable insights from complex studies.
What You'll Learn
Join us for a practical demonstration of how biotech startups and established pharmaceutical companies are solving this compliance challenge with the AI Rights add-on for Article Galaxy.
This solution eliminates the complex rights-checking process that currently burdens information professionals while enabling researchers to confidently use AI tools with scientific content.
In this targeted session for life sciences professionals, you'll discover:
- How to instantly verify AI usage permissions at the article level—eliminating compliance uncertainty across your organization
- The straightforward process for acquiring missing AI rights directly through the Article Galaxy interface
- How Article Galaxy consolidates rights from multiple sources (Open Access, CCC/CLA licenses, direct publisher agreements) in one seamless system
- Real-world examples from both biotech and pharma organizations managing copyright compliance for AI use at scale
Who Should Attend
This webinar is specifically designed for life sciences professionals including:
- R&D leaders in both biotech startups and established pharmaceutical companies
- Information professionals and Librarians managing scientific literature access
- Computational biology and bioinformatics teams utilizing AI for research
- Executives concerned with copyright compliance and innovation acceleration
- Clinical research organizations needing compliant literature analysis
Register now to learn how leading biotech and pharmaceutical organizations are transforming their biggest compliance risk into a competitive advantage in the AI-powered research landscape.